Fairfax Financial Holdings

L'entreprise

Fairfax owns a stable of property-and-casualty insurers and reinsurers (Northbridge, Odyssey Group, Allied World, Crum & Forster, Zenith, Brit and others) alongside a large, actively managed investment portfolio.

It also consolidates a range of non-insurance operating businesses, giving it a Berkshire-style structure of insurance float plus long-term investments.

2026 results have been strong, driven by solid underwriting and high investment income on a large fixed-income and equity portfolio.

Les avantages concurrentiels

Decades of disciplined P&C underwriting and a durable insurance-float engine that funds a value-oriented investment portfolio.

Scale and diversification across geographies and lines, plus a founder-led, long-horizon capital-allocation culture under Prem Watsa.

A long record of compounding book value per share, its central performance yardstick.

Aperçu financier

Période déclarée la plus récente : Q2 FY2026 (ended Jun 30, 2026). Les chiffres reflètent la date de révision — confirmez les chiffres actuels avant d'agir.

Rendement du flux de trésorerie disponible et croissance durable

Rendement des bénéfices : ≈12.2%TTM EPS of roughly C$286 on a ~C$2,347 share price implies a P/E of ~8x and an earnings yield of ~12% — but recent earnings are inflated by non-recurring investment gains, so normalized earnings yield is lower.

Sustainable growth comes from underwriting profit (a favorable combined ratio) plus recurring interest and dividend income on a large portfolio, compounded into book value per share.

High interest rates have boosted investment income; a sharp drop in rates or a hard turn in the underwriting cycle would slow the compounding.

Voir le classement complet du rendement des bénéfices →

Valorisation et points à surveiller

At roughly 8x trailing earnings, Fairfax screens cheaply, but a chunk of recent profit comes from investment gains that are inherently lumpy — the normalized earnings yield is lower than the headline ~12%.

Book value per share is the truer lens for Fairfax; the stock is best assessed on price-to-book and the durability of underwriting and investment income.

Dividende

Fairfax pays a single annual dividend of US$15 per share (roughly C$21), for a yield of about 0.9%. The token yield is deliberate — the company retains capital to compound book value rather than distribute it.

Risques et scénario baissier

• Earnings are inflated by investment gains that are volatile year to year; a weak investment year would sharply cut reported profit.
• Insurance is exposed to catastrophe losses and to a softening (weakening-price) underwriting cycle.
• Considerable financial and operating complexity across many subsidiaries, plus key-person reliance on Prem Watsa.

Faits récents

Q2 2026 (ended Jun 30, 2026): net income ~US$1.39B on revenue ~US$13.0B, with underwriting and investment results described as strong.

FY2025 delivered ~US$4.94B net income (+27%) on ~US$39.3B revenue (+13%).

Shares trade around C$2,347–2,407 with a market cap near C$47B and a P/E around 8x.

Verdict

Fairfax has quietly become one of the strongest compounders on the TSX: disciplined underwriting plus a large portfolio earning healthy investment income has driven multi-year book-value growth, and the stock still trades at only around 8x earnings. The caveat is that a meaningful part of profit is investment gains that will not repeat every year, so the true earnings power is lower than the headline suggests — this is a book-value-compounding story to judge over cycles, not a single P/E. CoinCompass is a publisher, not an adviser; read Fairfax's own reports before drawing conclusions.